MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Incremental Hospitalizations and Associated Costs of Co-existing Dementia in Patients with Parkinson’s Disease Psychosis: An analysis of US Medicare Beneficiaries

    N. Rashid, K. Rajagopalan, D. Gopal, D. Doshi (San Diego, USA)

    Objective: To evaluate incremental hospitalizations and costs among Medicare patients with Parkinson's disease psychosis (PDP) vs. PDP+dementia (PDP+D). Background: Research examining hospitalizations and costs of…
  • 2023 International Congress

    Epigenetic clock acceleration is linked to earlier onset and phenoconvertion of Rapid-eye-movement sleep behavior disorder

    K. Senkevich, A. Pelletier, C. Sato, A. Keil, Z. Gan-Or, A. Lang, R. Postuma, E. Rogaeva (Montreal, Canada)

    Objective: In the current study, we aim to evaluate whether Rapid-eye-movement sleep behavior disorder (RBD) age-at-onset and age-at-phenoconversion are associated with DNA methylation-age acceleration (DNAm-AA).…
  • 2023 International Congress

    Exosomal α-synuclein in Multiple system atrophy and parkinson’s disease cause distinct synucleinopathies

    X. Chi, L. Kou, Y. Sun, Y. Xia, T. Wang (Wuhan, China)

    Objective: In this study, we investigated the differences in exosomal α-syn between MSA and PD patients. Background: Parkinson's disease (PD) and multiple system atrophy (MSA)…
  • 2023 International Congress

    Asymmetric synaptic density and glucose consumption in subjects with non-demented Parkinson’s Disease, as measured with [11C]UCB-J and [18F]FDG PET.

    K. Andersen, A. Hansen, J. Horsager, K. Knudsen, P. Borghammer (Aarhus, Denmark)

    Objective: The objective of this study was to investigate asymmetric synaptic density and glucose consumption in moderate-stage non demented PD patients and the association between…
  • 2023 International Congress

    Cortical thickness and global atrophy progression in Parkinson’s disease with probable RBD

    J. Oltra, A. Campabadal, C. Uribe, J. Pardo, I. Roura, MJ. Martí, Y. Compta, F. Valldeoriola, N. Bargallo, A. Iranzo, C. Junque, B. Segura (Barcelona, Spain)

    Objective: To explore 3-year cortical thickness (CTh) and global atrophy progression in treated Parkinson’s disease (PD) with probable REM sleep behavior disorder (RBD). Background: Parkinson’s…
  • 2023 International Congress

    Efficacy and safety of Mexiletine versus Placebo in patients with myotonia: A Systematic Review and Meta-analysis

    A. Elettreby, A. Abo Elnaga, M. Alsaied (Mansoura, Egypt)

    Objective: We conducted this study to be the first systematic review and meta-analysis to investigate the efficacy and safety of mexiletine in the treatment of patients…
  • 2023 International Congress

    Optimal topographic characteristics of focused ultrasound unilateral thalamotomy for tremor-dominant Parkinson´s disease

    E. Natera-Villalba, JA. Pineda-Pardo, M. Del álamo, M. Matarazzo, R. Rodríguez-Rojas, R. Raimundo, R. Martínez-Fernández, JA. Obeso (Madrid, Spain)

    Objective: To define topography that correlates with tremor control after unilateral focused ultrasound (FUS) thalamotomy for tremor-dominant Parkinson´s Disease (TDPD). Background: Unilateral FUS thalamotomy of…
  • 2023 International Congress

    Challenges in patient-physician communication during limited time appointments in Parkinson’s disease

    E. Zhunusova, C. Shambetova, A. Iliazova (Bishkek, Kyrgyzstan)

    Objective: Our aim is to analyze challenges in patient-physician communication during limited time appointments in Parkinson’s disease (PD). Background: Due to limited number of movement…
  • 2023 International Congress

    Cell-specific MAPT gene expression is preserved in tau cytopathologies in Progressive Supranuclear Palsy

    S. Forrest, S. Lee, N. Nassir, V. Sackmann, I. Martinez-Valbuena1, J. Li, A. Ahmed, L. Ittner, A. Lang, M. Uddin, G. Kovacs (Toronto, Canada)

    Objective: To systematically map and quantify MAPT expression in neurons, astrocytes and oligodendroglia across different brain regions to determine whether cell type and/or regional differences…
  • 2023 International Congress

    Comparison of cognitive , affective and autonomic functions in parkinson’s disease patients with and without freezing of gait and its correlation with PET/CT

    K. Harisankar, S. Mehta, R. Kumar, M. Mohanty, S. Singh, N. Balaini, V. Lal (CHANDIGARH, India)

    Objective: To study and compare the cognitive, affective and autonomic domains in Parkinson’s disease patients with and without freezing of gait and to correlate with…
  • « Previous Page
  • 1
  • …
  • 167
  • 168
  • 169
  • 170
  • 171
  • …
  • 186
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • DaTscan in clinical evaluation of Multiple System Atrophy
    • Effect of marijuana on Essential Tremor: A case report
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley